Omniscient Neurotechnology

About:

Omniscient develops AI and data-driven solutions to improve treatment for brain disorders, providing predictive analytics for clinicians.

Website: https://www.o8t.com/

Twitter/X: o8tneuro

Top Investors: Gina Rinehart, Will Vicars

Description:

Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally. For more information, please visit www.o8t.com.

Total Funding Amount:

60M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sydney, New South Wales, Australia

Founded Date:

2019-01-01

Contact Email:

contact(AT)o8t.com

Founders:

Michael Sughrue, Stephane Doyen

Number of Employees:

51-100

Last Funding Date:

2024-06-11

IPO Status:

Private

© 2024 MyAiNote.com